About Symed
Symed is a company based in Hyderabad (India) founded in 1997 by Parthasaradi Reddy and Mohan Rao Dodda was acquired by Viyash in November 2021. The company has 949 employees as of April 08, 2024. Symed offers products and services including Active Pharmaceutical Ingredients and Contract Research Services. Symed operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 949 as on 08 Apr, 2024
- Founders Parthasaradi Reddy, Mohan Rao Dodda
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Symed Labs Limited
- Jurisdiction Shaikpet, Telangana, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Symed
Symed offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Contract Research Services.
Production of high-quality APIs for pharmaceutical applications
Provision of chemistry-related solutions for the industry
People of Symed
Unlock access to complete
Unlock access to complete
Funding Insights of Symed
Detailed funding history for Symed
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Symed
Symed has secured backing from 1 investor. Prominent investors backing the company include Viyash.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
APIs and intermediates are manufactured by Viyash as a CDMO.
|
Locked | Locked | Locked |
Investor details for Symed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Symed
Investment portfolio details for Symed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Symed
Detailed financials for Symed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Symed Comparisons
Peer comparison for Symed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Symed
Symed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Symed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Symed
Complete news archive for Symed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Symed
Symed was founded in 1997.
Symed is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Apr 08, 2024, the latest employee count at Symed is 949.
Annual revenue of Symed is $63.71M as on Mar 31, 2020.
Symed was founded in 1997 in Hyderabad, India, within the pharmaceutical sector. Active pharmaceutical ingredients are produced, alongside drug development services that support formulation and regulatory processes. Operations are centered in India, with a focus on API synthesis and custom development for global clients. Leadership includes co-founders Parthasaradi Reddy and Mohan Rao Dodda, who oversee manufacturing and strategic directions.
Symed's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Symed offers Active Pharmaceutical Ingredients and Contract Research Services.
Symed has 1 investor. Key investors include Viyash.